{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/TENX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T09:01:20.444Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":6029,"canonical_name":"TENAX THERAPEUTICS, INC.","cik":"0000034956","uei":null,"lei":null,"duns":null,"ticker":"TENX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":18},"count":18,"timeline":[{"ts":"2026-10-08","kind":"sec.filing","form_type":"8-K","title":"8-K — TENAX THERAPEUTICS, INC. — 2026-10-08","url_slug":"/sec/cik-0000034956/8-k/0001193125-26-417939","accession_number":"0001193125-26-417939","importance":35},{"ts":"2026-09-09","kind":"sec.filing","form_type":"8-K","title":"8-K — TENAX THERAPEUTICS, INC. — 2026-09-09","url_slug":"/sec/cik-0000034956/8-k/0001193125-26-385910","accession_number":"0001193125-26-385910","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — TENAX THERAPEUTICS, INC. — 2026-08-14","url_slug":"/sec/cik-0000034956/schedule-13g-a/0000921895-26-002186","accession_number":"0000921895-26-002186","importance":30},{"ts":"2026-08-10","kind":"sec.filing","form_type":"8-K","title":"8-K — TENAX THERAPEUTICS, INC. — 2026-08-10","url_slug":"/sec/cik-0000034956/8-k/0001193125-26-341236","accession_number":"0001193125-26-341236","importance":35},{"ts":"2026-07-31","kind":"sec.filing","form_type":"10-Q","title":"10-Q — TENAX THERAPEUTICS, INC. — 2026-07-31","url_slug":"/sec/cik-0000034956/10-q/0001193125-26-327455","accession_number":"0001193125-26-327455","importance":45},{"ts":"2026-07-31","kind":"sec.filing","form_type":"8-K","title":"8-K — TENAX THERAPEUTICS, INC. — 2026-07-31","url_slug":"/sec/cik-0000034956/8-k/0001193125-26-326784","accession_number":"0001193125-26-326784","importance":35},{"ts":"2026-07-13","kind":"sec.insider.m","reporter":"Giordano Christopher Thomas","title":"CEO","shares":8500,"price_per_share":5.94,"usd_value":50490,"security_title":"Common Stock","importance":15.05049},{"ts":"2026-07-13","kind":"sec.insider.m","reporter":"Giordano Christopher Thomas","title":"CEO","shares":219,"price_per_share":3.549,"usd_value":777,"security_title":"Common Stock","importance":15.000777231},{"ts":"2026-07-02","kind":"sec.filing","form_type":"8-K","title":"8-K — TENAX THERAPEUTICS, INC. — 2026-07-02","url_slug":"/sec/cik-0000034956/8-k/0001193125-26-293485","accession_number":"0001193125-26-293485","importance":35},{"ts":"2026-06-30","kind":"sec.filing","form_type":"8-K","title":"8-K — TENAX THERAPEUTICS, INC. — 2026-06-30","url_slug":"/sec/cik-0000034956/8-k/0001193125-26-290661","accession_number":"0001193125-26-290661","importance":35},{"ts":"2026-06-29","kind":"sec.filing","form_type":"8-K","title":"8-K — TENAX THERAPEUTICS, INC. — 2026-06-29","url_slug":"/sec/cik-0000034956/8-k/0001193125-26-288600","accession_number":"0001193125-26-288600","importance":35},{"ts":"2026-06-05","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — TENAX THERAPEUTICS, INC. — 2026-06-05","url_slug":"/sec/cik-0000034956/schedule-13g-a/0000080255-26-000435","accession_number":"0000080255-26-000435","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"8-K","title":"8-K — TENAX THERAPEUTICS, INC. — 2026-06-04","url_slug":"/sec/cik-0000034956/8-k/0001193125-26-257400","accession_number":"0001193125-26-257400","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — TENAX THERAPEUTICS, INC. — 2026-05-15","url_slug":"/sec/cik-0000034956/schedule-13g-a/0000921895-26-001400","accession_number":"0000921895-26-001400","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — TENAX THERAPEUTICS, INC. — 2026-05-12","url_slug":"/sec/cik-0000034956/10-q/0001193125-26-219383","accession_number":"0001193125-26-219383","importance":45},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — TENAX THERAPEUTICS, INC. — 2026-05-12","url_slug":"/sec/cik-0000034956/8-k/0001193125-26-218224","accession_number":"0001193125-26-218224","importance":35},{"ts":"2026-05-12","kind":"sec.filing","form_type":"S-8","title":"S-8 — TENAX THERAPEUTICS, INC. — 2026-05-12","url_slug":"/sec/cik-0000034956/s-8/0001193125-26-219772","accession_number":"0001193125-26-219772","importance":30},{"ts":"2026-05-11","kind":"sec.insider.a","reporter":"STAAB THOMAS R II","title":"Chief Financial Officer","shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15}]}